ANTILYMPHOMA TARGETING AGENTS WITH EFFECTOR AND AFFINITY FUNCTIONS LINKED BY A TRIFUNCTIONAL REAGENT

摘要

A medical agent comprising a reagent conjugated to an anti-lyrnphoma anibody is disclosed, as well as a kit containing said medical agent use of said medical agent, and a method for treatment of lymphoma. The reagent may comprise an effector, e.a. an antitumor asent or a diagnostic marker, and an affinity ligand enabling extracorporeal clearance of the agent. The three components are cound by a Afunctional linker.